About Us :: History
Currently ranked amongst the top pharmaceutical companies in the Indian Market,
Obsurge Biotech Ltd. Was established in the year 2002 by a group of pharma professionals
with a desire to provide relief from scourge of affordable prices to different sections
of the patients in the country. Today the desire stands transformed into reality
and we have established ourselves as the leading marketing entity with ISO 9001:
2008 certification. We are backed by untiring efforts to maintain continuity of
highest standards in quality manufacturing and our products have found excellent
acceptance by the medical profession and satisfied the users by offering excellent
results at reasonable prices. We are in the quest for excellence under the leadership
of our CMD Mr. J.S. Chauhan, a person with extensive experience in pharma sales
and marketing, production and finance.
We are aiming to get into top 10 pharma companies
in our covered market by 2012.We recorded total sales volume of Rs 320 millions
during the last fiscal year(* Confirmed by ORG-IMS 2009-10 audit). Our significant
emerging position in the domestic market can be estimated from our projected sales
volume of Rs. 500 million per annum during the current fiscal year and projected
sales volume of Rs 1 Billion per annum by the end of fiscal year 2013-2014 . As
an accomplished and reputed pharmaceutical company, our products are known for superior
quality and reliability by our esteemed customers all over India. We have continuous
improvement in areas of productivity, customer satisfaction and product quality.
Today, our products are well accepted by the medical fraternity across the country.
We have a network of approximately 300 trained field personnel expected to go upto
500 in next 12 months supported by knowledgeable professionals comprising our product
management team. We are handling our complete distribution chain of thousands of
stockists covering millions of retailers all over the country.
A collaboration with
a phrama major player from Europe is in advance stage which will help company to
service the medical fraternity with novel delivery systems for the molecules and
also make available products to fill up therapy gaps. We are also working on various
projects with Pharma companies in South east Asia.